GoodRx adds Publix pharmacies to its Gold network: We examine why working directly with pharmacies, as well as with PBMs, is important for GoodRx’s business.
AI healthcare milestone: The FDA’s greenlight for AI sepsis tech developed by Prenosis could help make hospitals and clinicians more comfortable with AI.
LGBT patients deal with discrimination in healthcare: Providers and marketers must step up to meet the needs of all patients. Here’s how they can do it.
Costco adds GLP-1 access to its new healthcare service: Online weight loss programs offer members fast access to doctors and meds—but not lower prices on the GLP-1 drugs themselves.
Retail clinics trail other providers in healthcare delivery: They may not be the market disruptors we once believed. Here’s why.
New power for digital stethoscope: An algorithm to help spot heart failure just won the FDA’s ok, and it’s backed by clinical evidence.
Insurers face reduced pay rates: Medicare Advantage insurers will see rates trimmed next year, adding pressure on firms like UnitedHealth and Humana to adapt. We could see MA benefits get slimmer.
Its latest AI model clones voices from short clips for varied applications. OpenAI is taking a cautious approach and leaning on partners to ensure ethical use.
Patients are less eager to share their health data now: Many don’t even want their doctors to have access. We explore how healthcare providers, marketers, and others can re-establish trust with consumers.
Wegovy coverage expands: Several health insurers will begin covering the weight loss injection for people who have heart disease. We think this will add pressure on manufacturers of the drug to cut costs.
A new path for digital treatments: Grow Therapy is partnering with Big Health, which makes apps that help people with insomnia, anxiety, and depression. Could they create a simpler way for insurers to pay for mental healthcare?
Tough requirements for medical meals: The Food is Medicine Coalition says medical meal providers should meet a high bar and be nonprofit.
An unexpected consequence of the surprise bill ban: Doctors are winning disputes with insurers over out-of-network bills, and their high charges could wind up raising costs for everyone.
Walgreens posts $6B loss as more VillageMD clinics close: The medical group’s underperformance is a cautionary tale for non-traditional primary care players.
Amazon invests in genAI for faster medication delivery: The tech giant hopes that AI will help get prescription drugs to consumers faster. It's still got plenty of competition from established pharmacy players, though.
Updated projections for US physician shortages are in: And they’re not as bleak as they were a few years ago. Here’s why.
Health tech gets slammed in new report: Most tech products for people with type 2 diabetes don’t offer meaningful medical benefits, and they cost more than standard care. Digital health startups need to prove their value to stand up to scrutiny.
More docs are charging for email communication: Health insurers are picking up most of the tabs, for now. That could change as subscription healthcare offerings and AI tools become more prevalent.
New uses for hot weight-loss drugs: Wegovy’s potential for preventing heart trouble and treating addiction could expand sales and counter insurers’ reluctance to pay for obesity treatments.
Biotech funding is surging: Investors are clamoring to bet on biotech startups, particularly ones with promising ideas that are already in clinical trials.